Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Sunshine Biopharma (SBFM) Times Interest Earned (2016 - 2024)

Sunshine Biopharma filings provide 11 years of Times Interest Earned readings, the most recent being -$238.92 for Q4 2024.

  • On a quarterly basis, Times Interest Earned fell 505.93% to -$238.92 in Q4 2024 year-over-year; TTM through Sep 2025 was -$759.14, a 1129.11% decrease, with the full-year FY2024 number at -$662.43, down 1800.74% from a year prior.
  • Times Interest Earned hit -$238.92 in Q4 2024 for Sunshine Biopharma, up from -$5176.6 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of -$1.99 in Q2 2021 to a low of -$858990.0 in Q3 2022.
  • Median Times Interest Earned over the past 5 years was -$26.56 (2024), compared with a mean of -$48104.3.
  • Biggest five-year swings in Times Interest Earned: plummeted 8109137.82% in 2022 and later skyrocketed 100.0% in 2023.
  • Sunshine Biopharma's Times Interest Earned stood at -$3.26 in 2020, then crashed by 134.44% to -$7.63 in 2021, then crashed by 11429.02% to -$880.12 in 2022, then soared by 95.52% to -$39.43 in 2023, then crashed by 505.93% to -$238.92 in 2024.
  • The last three reported values for Times Interest Earned were -$238.92 (Q4 2024), -$5176.6 (Q2 2024), and -$27.46 (Q1 2024) per Business Quant data.